Pathologic Stage II Esophageal Adenocarcinoma AJCC v8
generalStage IIA includes: (T2, N0, M0, G3); (T2, N0, M0, GX). T2: Tumor invades the muscularis propria. N0: No regional lymph node metastasis. M0: No distant metastasis. GX: Grade cannot be assessed. G3: Poorly differentiated, undifferentiated. (AJCC 8th ed.)
5
Centers
5
Active Trials
—
Cancer Funding
Top Centers for Pathologic Stage II Esophageal Adenocarcinoma AJCC v8(5)
Ranked by research excellence score (trials · grants · publications). Methodology →
| # | Center | Score |
|---|---|---|
| 1 | Memorial Sloan Kettering Cancer CenterNew York, NY NCI Comprehensive Active Research Program | 60.0 |
| 2 | The Ohio State University Comprehensive Cancer Center - James Cancer Hospital & Solove Research InstituteColumbus, OH NCI Comprehensive Active Research Program | 60.0 |
| 3 | City of Hope Comprehensive Cancer CenterDuarte, CA NCI Comprehensive Active Research Program | 60.0 |
| 4 | Moffitt Cancer CenterTampa, FL NCI Comprehensive Active Research Program | 60.0 |
| 5 | Boston University Cancer CenterBoston, MA Active Research Program | 60.0 |
Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →